LV11727A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
LV11727A
LV11727A LV950255A LV950255A LV11727A LV 11727 A LV11727 A LV 11727A LV 950255 A LV950255 A LV 950255A LV 950255 A LV950255 A LV 950255A LV 11727 A LV11727 A LV 11727A
Authority
LV
Latvia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
LV950255A
Other languages
Latvian (lv)
Other versions
LV11727B (en
Inventor
Ivars Kalvins
Maris Veveris
Original Assignee
Ivars Kalvins
Maris Veveris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivars Kalvins, Maris Veveris filed Critical Ivars Kalvins
Priority to LV950255A priority Critical patent/LV11727B/en
Priority to PCT/LV1996/000003 priority patent/WO1997006795A1/en
Publication of LV11727A publication Critical patent/LV11727A/en
Publication of LV11727B publication Critical patent/LV11727B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
LV950255A 1995-08-21 1995-08-21 Pharmaceutical composition LV11727B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LV950255A LV11727B (en) 1995-08-21 1995-08-21 Pharmaceutical composition
PCT/LV1996/000003 WO1997006795A1 (en) 1995-08-21 1996-08-20 Pharmaceutical compositions containing gamma-butyrobetain for treatment of blood flow disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LV950255A LV11727B (en) 1995-08-21 1995-08-21 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
LV11727A true LV11727A (en) 1997-04-20
LV11727B LV11727B (en) 1997-08-20

Family

ID=19736012

Family Applications (1)

Application Number Title Priority Date Filing Date
LV950255A LV11727B (en) 1995-08-21 1995-08-21 Pharmaceutical composition

Country Status (2)

Country Link
LV (1) LV11727B (en)
WO (1) WO1997006795A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1012495A3 (en) 1999-03-02 2000-11-07 Messadek Jallal Glycine betaine-for its use antithrombotic.
WO2002062322A2 (en) * 2001-02-05 2002-08-15 Jallal Messadek Glycine betaine and its use as anti-hemorrhagic agent
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
US20060233877A1 (en) * 2002-11-25 2006-10-19 Jallal Messadek Betaine compositions
CN1856461A (en) * 2003-07-28 2006-11-01 史密丝克莱恩比彻姆公司 Cycloalkylidene compounds as modulators of estrogen receptor
DK1667960T3 (en) * 2003-08-04 2008-06-09 Grindeks Jsc Meldonium salts, process for their preparation and pharmaceutical composition on their basis
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
RU2007143510A (en) 2005-04-27 2009-06-10 Яллал МЕССАДЕК (BE) INSULIN COMPOSITIONS
RS55092B1 (en) * 2011-04-27 2016-12-30 Grindeks Jsc Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (en) * 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION INCLUDING BUTYROBETAIN RANGE FOR THE TREATMENT OF SYNDROMES FROM CARNITIN DEFICIENCIES
IT1210935B (en) * 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
IT1157238B (en) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti USE OF 1-CARNITINA TO IMPROVE THE BIOCHEMICAL AND BEHAVIORAL PARAMENTS OF THE SENILE AGE
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
JPH01213259A (en) * 1988-02-23 1989-08-28 Kyowa Hakko Kogyo Co Ltd Purification of carnitine and carnitine amide

Also Published As

Publication number Publication date
WO1997006795A1 (en) 1997-02-27
LV11727B (en) 1997-08-20

Similar Documents

Publication Publication Date Title
NO20021172L (en) Pharmaceutical composition
IS4706A (en) pharmaceutical compositions
CY2005007I1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DARIFENACINE
FI944832A0 (en) Pharmaceutical composition
NO981008D0 (en) Pharmaceutical formulation
BR9607058A (en) Composition
BR9606809A (en) Insecticide-active composition
BR9610214A (en) Pharmaceutical compounds
ITMI932540A0 (en) PHARMACEUTICAL COMPOSITION
LV11727A (en) Pharmaceutical composition
DE69614407D1 (en) PHARMACEUTICAL COMPOSITIONS
FI973229A0 (en) New pharmaceutical composition
BR9507768A (en) Pharmaceutical composition
ID18698A (en) PHARMACEUTICAL COMPOSITION
FI973280A0 (en) Pharmaceutical composition
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
FI973230A (en) New pharmaceutical formulation
LV10579A (en) Pharmaceutical composition
BR9607946A (en) Composition
BR9605777A (en) Pharmaceutical composition
NO965448D0 (en) Pharmaceutical compounds
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
FI962738A (en) Pharmaceutical compositions
NO964309D0 (en) Pharmaceutical composition
IT1272935B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN